Overview
Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer.
Dr. Kalemkerian is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology. He is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 13 clinical trials. Dr. Kalemkerian is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr Fl 2, Ann Arbor, MI 48109
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Kalemkerian has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Frequently Asked Questions about Dr. Gregory P. Kalemkerian
How do I make an appointment with Dr. Gregory P. Kalemkerian?
You can book an appointment with Dr. Gregory P. Kalemkerian by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gregory P. Kalemkerian a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory P. Kalemkerian is classified as an Elite expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gregory P. Kalemkerian specialize in?
While Dr. Gregory P. Kalemkerian is a Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Gregory P. Kalemkerian participate in research or clinical trials?
Yes. Dr. Gregory P. Kalemkerian has published 81 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Gregory P. Kalemkerian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gregory P. Kalemkerian accept my insurance?
Dr. Gregory P. Kalemkerian accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Kalemkerian isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Kalemkerian isElite. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Kalemkerian isElite. Learn about Small Cell Lung Cancer (SCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Kalemkerian isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Kalemkerian isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Kalemkerian isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Kalemkerian isDistinguished. Learn about Lung Adenocarcinoma.
- MesotheliomaDr. Kalemkerian isDistinguished. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Kalemkerian isDistinguished. Learn about Metastatic Pleural Tumor.
- Pleuropulmonary BlastomaDr. Kalemkerian isDistinguished. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Kalemkerian isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Kalemkerian isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Squamous Cell Lung CarcinomaDr. Kalemkerian isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Metastatic Brain TumorDr. Kalemkerian isAdvanced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Kalemkerian isAdvanced. Learn about Neuroendocrine Tumor.
- Thymic Epithelial TumorDr. Kalemkerian isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- AgranulocytosisDr. Kalemkerian isExperienced. Learn about Agranulocytosis.
- Brain TumorDr. Kalemkerian isExperienced. Learn about Brain Tumor.
- Cushing's syndrome due to Adrenal TumorDr. Kalemkerian isExperienced. Learn about Cushing's syndrome due to Adrenal Tumor.
- EmphysemaDr. Kalemkerian isExperienced. Learn about Emphysema.
- Lung NodulesDr. Kalemkerian isExperienced. Learn about Lung Nodules.
- Mediastinal TumorDr. Kalemkerian isExperienced. Learn about Mediastinal Tumor.
- Opioid Induced ConstipationDr. Kalemkerian isExperienced. Learn about Opioid Induced Constipation.
- Pancreatic CancerDr. Kalemkerian isExperienced. Learn about Pancreatic Cancer.
- Pseudomyxoma PeritoneiDr. Kalemkerian isExperienced. Learn about Pseudomyxoma Peritonei.
- Severe Congenital NeutropeniaDr. Kalemkerian isExperienced. Learn about Severe Congenital Neutropenia.
- Stomach CancerDr. Kalemkerian isExperienced. Learn about Stomach Cancer.
- ThrombocytopeniaDr. Kalemkerian isExperienced. Learn about Thrombocytopenia.